ASF Research Grants
ASF Research Grants from the Angelman Syndrome Foundation fund global, collaborative research to advance treatments and scientific understanding of Angelman syndrome.
Browse similar grants
Funder: Angelman Syndrome Foundation
Due Dates: August 15, 2027 (Annual proposal submission deadline)
Funding Amounts: Up to $100,000 per year; one- or two-year grants; indirect costs capped at 10% within total budget.
Summary: Funds innovative global research to advance treatments and care for Angelman syndrome, prioritizing scientific breakthroughs and collaboration.
Description
The Angelman Syndrome Foundation (ASF) Research Grants program supports innovative scientific research aimed at accelerating effective treatments and improving care for individuals with Angelman syndrome (AS). The program is global in scope and encourages proposals from researchers, clinicians, and institutions whose work aligns with ASF’s comprehensive Research Roadmap. This roadmap emphasizes advances in UBE3A regulation, novel therapeutic strategies (including gene therapy and small molecules), clinical care innovation, and the development of objective therapeutic endpoints and biomarkers. ASF fosters collaboration among geneticists, neuroscientists, clinicians, and industry partners to translate scientific discoveries into real-world solutions for the AS community.
